Get startedLog in
    Picture of Marksans Pharma logo

    MARKSANS — Marksans Pharma Cashflow Statement

    0.000.00%
    in flag iconLast trade - 00:00
    HealthcareAdventurousMid CapHigh Flyer
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Marksans Pharma, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

    2021
    March 31st
    R2022
    March 31st
    2023
    March 31st
    2024
    March 31st
    2025
    March 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSPRESS
    Standards:
    IAS
    IAS
    IAS
    IAS    		—
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line3,0222,4753,3774,2355,040
    Depreciation
    Non-Cash Items421-94.7224-188-140
    Unusual Items
    Other Non-Cash Items
    Changes in Working Capital-2,017-1,836-1,745-2,485-3,667
    Change in Accounts Receivable
    Change in Inventories
    Change in Other Assets
    Change in Accounts Payable
    Change in Other Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities1,7879932,3742,3042,067
    Capital Expenditures-464-463-536-2,088-1,729
    Purchase of Fixed Assets
    Other Investing Cash Flow Items15.3-381-2,0566801,239
    Acquisition of Business
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Change in Net Investments
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities-449-844-2,592-1,408-490
    Financing Cash Flow Items-79.9-42.2-60.7-51.7-23.9
    Other Financing Cash Flow
    Total Cash Dividends Paid
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities-1537951,978-687-651
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash1,1869441,760208925